24 research outputs found
Natural history and determinants of dysglycemia in Canadian children with parental obesity from ages 8â10 to 15â17âyears : the QUALITY cohort
In children, the mechanisms implicated in deterioration of glucose homeostasis versus reversion to normal glucose tolerance (NGT) remain uncertain. We aimed to describe the natural history of dysglycemia from childhood to late adolescence and to identify its early determinants. We used baseline (8â10âyears, n = 630), 1st follow-up (10â12âyears, n = 564) and 2nd follow-up (15â17âyears, n = 377) data from the QUALITY cohort of White Canadian children with parental obesity. Children underwent a 2-h oral glucose tolerance test at each cycle with plasma glucose and insulin measured at 0/30/60/90/120âmin. American Diabetes Association criteria defined dysglycemia (impaired fasting glucose, impaired glucose tolerance or type 2 diabetes). Longitudinal patterns of insulin sensitivity and beta-cell function were estimated using generalized additive mixed models. Model averaging identified biological, sociodemographic and lifestyle-related determinants of dysglycemia. Of the children NGT at baseline, 66 (21%) developed dysglycemia without reverting to NGT. Among children with dysglycemia at baseline, 24 (73%) reverted to NGT. In children with dysglycemia at 1st follow-up, 18 (53%) later reverted to NGT. Among biological, sociodemographic and lifestyle determinants at 8â10âyears, only fasting and 2-h glucose were associated with developing dysglycemia (odds ratio [95% CI] per 1âmmol/L increase: 4.50 [1.06; 19.02] and 1.74 [1.11; 2.73], respectively). Beta-cell function decreased by 40% in children with overweight or obesity. In conclusion, up to 75% of children with dysglycemia reverted to NGT during puberty. Children with higher fasting and 2-h glucose were at higher risk for progression to dysglycemia, while no demographic/lifestyle determinants were identified
The APOGEE-2 Survey of the Orion Star Forming Complex: I. Target Selection and Validation with early observations
The Orion Star Forming Complex (OSFC) is a central target for the APOGEE-2
Young Cluster Survey. Existing membership catalogs span limited portions of the
OSFC, reflecting the difficulty of selecting targets homogeneously across this
extended, highly structured region. We have used data from wide field
photometric surveys to produce a less biased parent sample of young stellar
objects (YSOs) with infrared (IR) excesses indicative of warm circumstellar
material or photometric variability at optical wavelengths across the full 420
square degrees extent of the OSFC. When restricted to YSO candidates with H <
12.4, to ensure S/N ~100 for a six visit source, this uniformly selected sample
includes 1307 IR excess sources selected using criteria vetted by Koenig &
Liesawitz and 990 optical variables identified in the Pan-STARRS1 3
survey: 319 sources exhibit both optical variability and evidence of
circumstellar disks through IR excess. Objects from this uniformly selected
sample received the highest priority for targeting, but required fewer than
half of the fibers on each APOGEE-2 plate. We fill the remaining fibers with
previously confirmed and new color-magnitude selected candidate OSFC members.
Radial velocity measurements from APOGEE-1 and new APOGEE-2 observations taken
in the survey's first year indicate that ~90% of the uniformly selected targets
have radial velocities consistent with Orion membership.The APOGEE-2 Orion
survey will include >1100 bona fide YSOs whose uniform selection function will
provide a robust sample for comparative analyses of the stellar populations and
properties across all sub-regions of Orion.Comment: Accepted for publication in ApJ
Mitchell-Riley Syndrome : Improving Clinical Outcomes and Searching for Functional Impact of RFX-6 Mutations
Aims/HypothesisCaused by biallelic mutations of the gene encoding the transcription factor RFX6, the rare Mitchell-Riley syndrome (MRS) comprises neonatal diabetes, pancreatic hypoplasia, gallbladder agenesis or hypoplasia, duodenal atresia, and severe chronic diarrhea. So far, sixteen cases have been reported, all with a poor prognosis. This study discusses the multidisciplinary intensive clinical management of 4 new cases of MRS that survived over the first 2 years of life. Moreover, it demonstrates how the mutations impair the RFX6 function. MethodsClinical records were analyzed and described in detail. The functional impact of two RFX6(R181W) and RFX6(V506G) variants was assessed by measuring their ability to transactivate insulin transcription and genes that encode the L-type calcium channels required for normal pancreatic beta-cell function. ResultsAll four patients were small for gestational age (SGA) and prenatally diagnosed with duodenal atresia. They presented with neonatal diabetes early in life and were treated with intravenous insulin therapy before switching to subcutaneous insulin pump therapy. All patients faced recurrent hypoglycemic episodes, exacerbated when parenteral nutrition (PN) was disconnected. A sensor-augmented insulin pump therapy with a predictive low-glucose suspension system was installed with good results. One patient had a homozygous c.1517T>G (p.Val506Gly) mutation, two patients had a homozygous p.Arg181Trp mutation, and one patient presented with new compound heterozygosity. The RFX6(V506G) and RFX6(R181W) mutations failed to transactivate the expression of insulin and genes that encode L-type calcium channel subunits required for normal pancreatic beta-cell function. Conclusions/InterpretationMultidisciplinary and intensive disease management improved the clinical outcomes in four patients with MRS, including adjustment of parenteral/oral nutrition progression and advanced diabetes technologies. A better understanding of RFX6 function, in both intestine and pancreas cells, may break ground in new therapies, particularly regarding the use of drugs that modulate the enteroendocrine system.Peer reviewe
Randomized controlled trial of early arachidonic acid and docosahexaenoic acid enteral supplementation in very preterm infants
[Objective]: To evaluate changes in blood long-chain polyunsaturated fatty acid (LCPUFA) and oxylipin concentrations in very preterm infants from birth to 36 weeksâ postmenstrual age (WPA) after providing an emulsified arachidonic acid (ARA):docosahexaenoic acid (DHA) supplement at two different concentrations.[Study design]: This prospective, randomized trial assigned infants to receive a supplement (1) 80:40 group (80 mg/kg/day ARA and 40 mg/kg/day DHA, n = 9) or (2) 120:60 group (120 mg/kg/day ARA and 60 mg/kg/day DHA, n = 9). Infants received supplement daily from birth until 36 WPA. At baseline, 21 days of life and 36 WPA, the LCPUFAs were measured in plasma by gas chromatography/mass spectrophotometry. Additionally, LCPUFAs and oxylipins were analyzed in whole blood by ultra-high-performance liquid chromatography-tandem mass spectrometry. Furthermore, a sample of oral mucosa was obtained to analyze single-nucleotide polymorphism located in the FADS1 gene by PCR.[Results]: Gestational age was similar between groups (80:40 = 28+6 [27+3; 30+3] completed weeks+days; 120:60 = 29+6 [27+3; 30+5] completed weeks+days, p = 0.83). At 36 WPA, the change in plasma ARA was significantly different between groups (80:40 group = 0.15 [â0.67; 0.69] %nmol, 120:60 = 1.68 [1.38; 3.16] %nmol, p = 0.031). In whole blood, the levels of ARA-derived oxylipins (5-, 8-, 9-, 11-, 15-HETE and 8,9-EET) and EPA-derived oxylipins (18-HEPE) significantly increase from baseline to 36 WPA in the 120:60 group than the 80:40 group.[Conclusion]: Supplementation at high doses (120:60 mg/kg/day) increased levels of ARA, and EPA- and ARA-derived oxylipins compared to low doses (80:40 mg/kg/day). Differences were detected in EPA metabolites without a significant increase in plasma DHA.This article was supported by the 20th National Grants for Research in Life Sciences 2021/2021 from RamĂłn Areces Foundation (Spain), the European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) networking grant 2021, and Spanish Programs for the generation of Knowledge and Scientific and Technological strengthening of the system and oriented to the challenges of Society (PID2020-119084RB-C21 and PID2020-114821RB-I00 funded by MCIN/AEI/10.13039/501100011033) from the Ministry of Science and Innovation (Spain).Peer reviewe
The Eighteenth Data Release of the Sloan Digital Sky Surveys: Targeting and First Spectra from SDSS-V
The eighteenth data release of the Sloan Digital Sky Surveys (SDSS) is the
first one for SDSS-V, the fifth generation of the survey. SDSS-V comprises
three primary scientific programs, or "Mappers": Milky Way Mapper (MWM), Black
Hole Mapper (BHM), and Local Volume Mapper (LVM). This data release contains
extensive targeting information for the two multi-object spectroscopy programs
(MWM and BHM), including input catalogs and selection functions for their
numerous scientific objectives. We describe the production of the targeting
databases and their calibration- and scientifically-focused components. DR18
also includes ~25,000 new SDSS spectra and supplemental information for X-ray
sources identified by eROSITA in its eFEDS field. We present updates to some of
the SDSS software pipelines and preview changes anticipated for DR19. We also
describe three value-added catalogs (VACs) based on SDSS-IV data that have been
published since DR17, and one VAC based on the SDSS-V data in the eFEDS field.Comment: Accepted to ApJ
The eighteenth data release of the Sloan Digital Sky Surveys : targeting and first spectra from SDSS-V
The eighteenth data release of the Sloan Digital Sky Surveys (SDSS) is the first one for SDSS-V, the fifth generation of the survey. SDSS-V comprises three primary scientific programs, or "Mappers": Milky Way Mapper (MWM), Black Hole Mapper (BHM), and Local Volume Mapper (LVM). This data release contains extensive targeting information for the two multi-object spectroscopy programs (MWM and BHM), including input catalogs and selection functions for their numerous scientific objectives. We describe the production of the targeting databases and their calibration- and scientifically-focused components. DR18 also includes ~25,000 new SDSS spectra and supplemental information for X-ray sources identified by eROSITA in its eFEDS field. We present updates to some of the SDSS software pipelines and preview changes anticipated for DR19. We also describe three value-added catalogs (VACs) based on SDSS-IV data that have been published since DR17, and one VAC based on the SDSS-V data in the eFEDS field.Publisher PDFPeer reviewe
Prevalence and characteristics of polycystic ovary syndrome in obese adolescents
Introdução: o diagnĂłstico da SĂndrome do OvĂĄrio PolicĂstico (SOP) na adolescĂȘncia Ă© desafiador e vem sendo alvo de intensas discussĂ”es. Sua prevalĂȘncia em mulheres adultas em idade fĂ©rtil varia de 5-10%. Entretanto, a prevalĂȘncia em adolescentes obesas ainda nĂŁo foi descrita na literatura. Somado a isso, ainda nĂŁo Ă© bem estabelecida a relação da SOP com alteraçÔes metabĂłlicas e cardiovasculares nesta população. Dessa maneira, objetivamos avaliar a prevalĂȘncia e as caracterĂsticas da SOP na população de adolescentes obesas acompanhadas em um centro hospitalar quaternĂĄrio. MĂ©todos: realizamos um estudo transversal com 49 adolescentes obesas pĂłs-menarca, com idade mĂ©dia de 15,6 anos. Foi realizada avaliação antropomĂ©trica e revisĂŁo de prontuĂĄrios mĂ©dicos. O hiperandrogenismo clĂnico e laboratorial foram quantificados utilizando o Ăndice de Ferriman-Gallwey e as dosagens androgĂȘnicas, respectivamente. A morfologia ovariana foi avaliada por ultrassonografia suprapĂșbica. Todas as pacientes tiveram seus perfis metabĂłlicos analisados. Resultados: ao adotarmos a nova Diretriz para SOP na adolescĂȘncia da Sociedade de Endocrinologia PediĂĄtrica Americana, encontramos uma prevalĂȘncia de 18,4% de SOP em nossa população de adolescentes obesas. Quando utilizamos os critĂ©rios de Rotterdam, da Sociedade de Excesso AndrogĂȘnico e SOP e do Instituto Nacional de SaĂșde Americano, as prevalĂȘncias foram de 26,4%, 22,4% e 20,4%, respectivamente. A irregularidade menstrual foi constatada em 65,3% das pacientes. O hiperandrogenismo clĂnico foi observado em 16,3% das meninas, e 18,4% tinham concentraçÔes de testosterona total acima do valor de normalidade. A ultrassonografia revelou que 18,4% das meninas tinham ovĂĄrios policĂsticos. Adolescentes obesas com SOP apresentaram maior prevalĂȘncia de sĂndrome metabĂłlica. ConclusĂŁo: a prevalĂȘncia de SOP em adolescentes obesas Ă© alta quando comparada Ă quela observada na literaturaBackground: polycystic ovary syndrome (PCOS) in adolescence is a challenging diagnosis and therefore has raised intense discussions. Its prevalence in childbearing age women ranges from 5 to 10%. However, the prevalence in obese adolescents has not yet been reported. Besides, the relationship of PCOS with metabolic and cardiovascular disorders in this specific population has not been established. Thus, we aimed to assess the prevalence and characteristics of PCOS in a population of obese adolescents followed at a quarternary hospital. Methods: we performed a cross-sectional study with 49 postmenarcheal obese adolescents with a mean age of 15.6 years. Anthropometric assessment and review of medical records were performed. Clinical and laboratory hyperandrogenism were evaluated using Ferriman-Gallwey index and serum androgens, respectively. The ovarian morphology was evaluated by supra-pubic ultrasound. All patients had their metabolic profile evaluated. Results: the prevalence of PCOS in obese adolescents, according to the new guideline for PCOS in adolescence of the American Pediatric Endocrinology Society, was 18.4%. When assessed by the Rotterdam, the Androgen Excess and PCOS Society and the National Institute of Health criteria, the prevalence of PCOS was 26.4%, 22.4% and 20.4%, respectively. Menstrual irregularity was found in 65.3% of the patients. Clinical hyperandrogenism was observed in 16.3% while 18.4% had total testosterone concentrations above the normal range. Ultrasonography revealed that 18.4% had polycystic ovaries. Obese adolescents with PCOS had higher prevalence of metabolic syndrome. Conclusion: the prevalence of PCOS in obese adolescents is high compared to that observed in the literatur
Prevalence and characteristics of polycystic ovary syndrome in obese adolescents
Introdução: o diagnĂłstico da SĂndrome do OvĂĄrio PolicĂstico (SOP) na adolescĂȘncia Ă© desafiador e vem sendo alvo de intensas discussĂ”es. Sua prevalĂȘncia em mulheres adultas em idade fĂ©rtil varia de 5-10%. Entretanto, a prevalĂȘncia em adolescentes obesas ainda nĂŁo foi descrita na literatura. Somado a isso, ainda nĂŁo Ă© bem estabelecida a relação da SOP com alteraçÔes metabĂłlicas e cardiovasculares nesta população. Dessa maneira, objetivamos avaliar a prevalĂȘncia e as caracterĂsticas da SOP na população de adolescentes obesas acompanhadas em um centro hospitalar quaternĂĄrio. MĂ©todos: realizamos um estudo transversal com 49 adolescentes obesas pĂłs-menarca, com idade mĂ©dia de 15,6 anos. Foi realizada avaliação antropomĂ©trica e revisĂŁo de prontuĂĄrios mĂ©dicos. O hiperandrogenismo clĂnico e laboratorial foram quantificados utilizando o Ăndice de Ferriman-Gallwey e as dosagens androgĂȘnicas, respectivamente. A morfologia ovariana foi avaliada por ultrassonografia suprapĂșbica. Todas as pacientes tiveram seus perfis metabĂłlicos analisados. Resultados: ao adotarmos a nova Diretriz para SOP na adolescĂȘncia da Sociedade de Endocrinologia PediĂĄtrica Americana, encontramos uma prevalĂȘncia de 18,4% de SOP em nossa população de adolescentes obesas. Quando utilizamos os critĂ©rios de Rotterdam, da Sociedade de Excesso AndrogĂȘnico e SOP e do Instituto Nacional de SaĂșde Americano, as prevalĂȘncias foram de 26,4%, 22,4% e 20,4%, respectivamente. A irregularidade menstrual foi constatada em 65,3% das pacientes. O hiperandrogenismo clĂnico foi observado em 16,3% das meninas, e 18,4% tinham concentraçÔes de testosterona total acima do valor de normalidade. A ultrassonografia revelou que 18,4% das meninas tinham ovĂĄrios policĂsticos. Adolescentes obesas com SOP apresentaram maior prevalĂȘncia de sĂndrome metabĂłlica. ConclusĂŁo: a prevalĂȘncia de SOP em adolescentes obesas Ă© alta quando comparada Ă quela observada na literaturaBackground: polycystic ovary syndrome (PCOS) in adolescence is a challenging diagnosis and therefore has raised intense discussions. Its prevalence in childbearing age women ranges from 5 to 10%. However, the prevalence in obese adolescents has not yet been reported. Besides, the relationship of PCOS with metabolic and cardiovascular disorders in this specific population has not been established. Thus, we aimed to assess the prevalence and characteristics of PCOS in a population of obese adolescents followed at a quarternary hospital. Methods: we performed a cross-sectional study with 49 postmenarcheal obese adolescents with a mean age of 15.6 years. Anthropometric assessment and review of medical records were performed. Clinical and laboratory hyperandrogenism were evaluated using Ferriman-Gallwey index and serum androgens, respectively. The ovarian morphology was evaluated by supra-pubic ultrasound. All patients had their metabolic profile evaluated. Results: the prevalence of PCOS in obese adolescents, according to the new guideline for PCOS in adolescence of the American Pediatric Endocrinology Society, was 18.4%. When assessed by the Rotterdam, the Androgen Excess and PCOS Society and the National Institute of Health criteria, the prevalence of PCOS was 26.4%, 22.4% and 20.4%, respectively. Menstrual irregularity was found in 65.3% of the patients. Clinical hyperandrogenism was observed in 16.3% while 18.4% had total testosterone concentrations above the normal range. Ultrasonography revealed that 18.4% had polycystic ovaries. Obese adolescents with PCOS had higher prevalence of metabolic syndrome. Conclusion: the prevalence of PCOS in obese adolescents is high compared to that observed in the literatur
Children With Metabolically Healthy Obesity: A Review
International audienceChildren with "metabolically healthy obesity" (MHO) are a distinct subgroup of youth with obesity, who are less prone to the clustering of cardiometabolic risk factors. Although this phenotype, frequently defined by the absence of metabolic syndrome components or insulin resistance, was first described during the early 1980s, a consensus-based definition of pediatric MHO was introduced only recently, in 2018. The purpose of this review was to concisely summarize current knowledge regarding the MHO phenomenon in youth. The prevalence of MHO in children varies from 3 to 87%, depending on the definition used and the parameters evaluated, as well as the ethnicity and the pubertal status of the sample. The most consistent predictors of MHO in youth include younger age, lower body mass index, lower waist circumference, and lower body fat measurements. Various hypotheses have been proposed to elucidate the underlying factors maintaining the favorable MHO phenotype. While preserved insulin sensitivity and lack of inflammation were previously considered to be the main etiological factors, the most recent findings have implicated adipokine levels, the number of inflammatory immune cells in the adipose tissue, and the reduction of visceral adiposity due to adipose tissue expandability. Physical activity and genetic factors also contribute to the MHO phenotype. Obesity constitutes a continuum-increased risk for cardiometabolic complications, which is less evident in children with MHO. However, some findings have highlighted the emergence of hepatic steatosis, increased carotid intima-media thickness and inflammatory biomarkers in the MHO group compared to peers without obesity. Screening should be directed at those more likely to develop clustering of cardiometabolic risk factors. Lifestyle modifications should include behavioral changes focusing on sleep duration, screen time, diet, physical activity, and tobacco smoke exposure. Weight loss has also been associated with the improvement of insulin sensitivity and inflammation. Further investigative efforts are needed in order to elucidate the mechanisms which protect against the clustering of cardiometabolic risk factors in pediatric obesity, to provide more efficient, targeted treatment approaches for children with obesity, and to identify the protective factors preserving the MHO profile, avoiding the crossover of MHO to the phenotype with metabolically unhealthy obesity
How does Clusters of Parental Characteristics Influences Offspring Adiposity: A Prospective Study
International audienceIntroduction: Childhood obesity rates have increased exponentially in the past three decades. Parental characteristics, such as weight status, physical activity (PA), education and smoking habits have been identified individually as being potential determinants of offspring obesity. However, no prospective studies have examined the joint impact of parental lifestyle habits on their offspring's adiposity. We identified clusters of parental characteristics, and estimated their influence on offspring adiposity in late adolescence.Methods: Data stem from the QUALITY Cohort, a longitudinal study of children with at least one obese parent. Children were evaluated at 8-10y (n=630), 10-12y (n=564), and 15-17y (n=377). Parental smoking habits, PA and education were self-reported. Weight and height were obtained and body mass index (BMI) was calculated. Cluster analysis was performed on 209 families with complete data across all 3 evaluation cycles. We performed cluster analysis on mothers and fathers separately using partitioning around medoids (PAM) to identify parental phenotype clusters based on 4 parental characteristics (BMI, PA, education and smoking habits). Linear regressions, adjusted for child age, sex and Tanner stage, were used to assess associations between clusters (mothers and fathers) and measures of childhood adiposity (BMI z-score) at 15-17y.Results: Three clusters were identified among mothers and four clusters among fathers. Mothers in cluster 1 (n=18) were obese, less educated, smoked, and tended to be more active; cluster 2 (n=109) were overweight, educated and non-smokers; cluster 3 (n=82) were overweight, less educated, non-smokers and tended to be less active. Fathers in cluster 1 (n=109) were less educated and non-smokers, cluster 2 (n=68) were educated and non-smokers, cluster 3 (n=23) were less educated and smokers and cluster 4 (n=9) were older, educated and smokers.Children of obese, less educated and smoking mothers(cluster 1) had higher adiposity measurements compared with children of overweight, educated, non-smokingmothers (cluster 2), with an increase in BMI z-score of +0.94 (95% CI: 0.35-1.53); P=0.002. Child adiposity measurements were comparable across father phenotype clusters.Conclusions: Targeting obese and less educated mothers who smoke to promote the adoption of healthier lifestyle habits may be effective at preventing later adiposity in their offspring